http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008169148-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a177f0fa84b1b2134e13caa36974ce3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2007-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e82903b160d0c4b0ff838f6188ca55d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_538507ddaac930fac3fc95443f286724 |
| publicationDate | 2008-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008169148-A |
| titleOfInvention | Synovial sarcoma treatment |
| abstract | PROBLEM TO BE SOLVED: To provide an anticancer agent that can be used for treatment of synovial sarcoma. A therapeutic agent for synovial sarcoma comprising an Src family tyrosine kinase inhibitor as an active ingredient. The present invention can inhibit proliferation, invasion, and / or metastasis specifically in synovial sarcoma cells, and can significantly improve the treatment prognosis than before. [Selection figure] None |
| priorityDate | 2007-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.